| Year |
Title |
Altmetric |
| 2020
|
Anchored Transponder Guided Lung Radiation Therapy.
Practical Radiation Oncology.
10:e37-e44.
2020
|
|
| 2019
|
Electromagnetic Transponder Based Tracking and Gating in the Radiotherapeutic Treatment of Thoracic Malignancies.
Practical Radiation Oncology.
9:456-464.
2019
|
|
| 2019
|
Feasibility of Dose Escalating [18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer.
Advances in Radiation Oncology.
4:649-658.
2019
|
|
| 2019
|
Longitudinal assessment of anchored transponder migration following lung stereotactic body radiation therapy.
Journal of Applied Clinical Medical Physics.
20:17-22.
2019
|
|
| 2019
|
Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines.
Journal of the National Comprehensive Cancer Network.
17:1464-1472.
2019
|
|
| 2019
|
Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial.
Advances in Radiation Oncology.
4:90-95.
2019
|
|
| 2018
|
NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines.
Journal of the National Comprehensive Cancer Network.
16:1171-1182.
2018
|
|
| 2018
|
NCCN guidelines ® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines.
Journal of the National Comprehensive Cancer Network.
16:807-821.
2018
|
|
| 2018
|
Safety and outcome measures of first-in-human intraperitoneal α radioimmunotherapy with 212 Pb-TCMC-Trastuzumab.
American Journal of Clinical Oncology.
41:716-721.
2018
|
|
| 2018
|
Stereotactic Radiosurgery for Prostate Cancer Following Magnetic Resonance Imaging Directed Biopsy: A Multidisciplinary Approach with Case Examples..
Cureus.
10:e2524.
2018
|
|
| 2017
|
Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer.
Urologic Oncology: Seminars and Original Investigations.
35:663.e15-663.e21.
2017
|
|
| 2017
|
Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network.
15:504-535.
2017
|
|
| 2017
|
Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: A secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial.
Journal of Clinical Oncology.
35:56-62.
2017
|
|
| 2016
|
Analysis of Predictive Factors for Acute Esophagitis in Lung Cancer Radiation Therapy..
International Journal of Radiation Oncology - Biology - Physics.
96:E193-E194.
2016
|
|
| 2016
|
Analysis of Predictive Factors for Pneumonitis in Lung Cancer Radiation Therapy..
International Journal of Radiation Oncology - Biology - Physics.
96:E482-E483.
2016
|
|
| 2016
|
Correction: Kinomic profiling of electromagnetic navigational bronchoscopy specimens: A new approach for personalized medicine (PLoS ONE (2016) 9:12 (e116388) DOI: 10.1371/journal.pone.0116388).
PLoS ONE.
11.
2016
|
|
| 2016
|
NCCN Guidelines®: Insights malignant pleural mesothelioma, version 3.2016.
Journal of the National Comprehensive Cancer Network.
14:825-836.
2016
|
|
| 2016
|
NCCN guidelines® Insights: Non-small cell lung cancer, version 4.2016 Featured updates to the NCCN guidelines.
Journal of the National Comprehensive Cancer Network.
14:255-264.
2016
|
|
| 2016
|
Long-term outcomes among patients who achieve complete or near-complete responses after the induction phase of bladder-preserving combined-modality therapy for muscle-invasive bladder cancer: A pooled analysis of NRG Oncology/RTOG 9906 and 0233.
International Journal of Radiation Oncology - Biology - Physics.
94:67-74.
2016
|
|
| 2015
|
Non-Small Cell Lung Cancer, Version 6.2015..
Journal of the National Comprehensive Cancer Network.
13:515-524.
2015
|
|
| 2015
|
Non-Small cell lung cancer, version 6.2015: Featured updates to the NCCN guidelines.
Journal of the National Comprehensive Cancer Network.
13:515-524.
2015
|
|
| 2015
|
A phase 3 trial of 2 years of androgen suppression and radiation therapy with or without adjuvant chemotherapy for high-risk prostate cancer: Final results of radiation therapy oncology group phase 3 randomized trial NRG oncology RTOG 9902.
International Journal of Radiation Oncology - Biology - Physics.
93:294-302.
2015
|
|
| 2015
|
Continuous chemoradiation following complete response to neo-adjuvant chemotherapy provides improved outcomes in muscle invasive urothelial carcinoma.
Journal of Solid Tumors.
5:59-68.
2015
|
|
| 2015
|
Retention rate of electromagnetic navigation bronchoscopic placed fiducial markers for lung radiosurgery.
Annals of Thoracic Surgery.
100:1163-1166.
2015
|
|
| 2014
|
Kinomic profiling of electromagnetic navigational bronchoscopy specimens: A new approach for personalized medicine.
PLoS ONE.
9.
2014
|
|
| 2014
|
Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide.
Radiation Oncology.
9.
2014
|
|
| 2014
|
Comparison of plan quality and delivery time between volumetric arc therapy (rapidarc) and gamma knife radiosurgery for multiple cranial metastases.
Neurosurgery.
75:409-417.
2014
|
|
| 2014
|
PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalation.
Urologic Oncology: Seminars and Original Investigations.
32:687-693.
2014
|
|
| 2013
|
Effects of flattening filter-free and volumetric-modulated arc therapy delivery on treatment efficiency..
Journal of Applied Clinical Medical Physics.
14:4328.
2013
|
|
| 2013
|
Stereotactic body radiation therapy (SBRT) for lung malignancies: Preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute.
Radiation Oncology.
8.
2013
|
|
| 2013
|
Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer.
Acta Oncologica.
52:1181-1188.
2013
|
|
| 2013
|
Patient benefit from salvage radiation for prostate cancer..
Journal of Clinical Oncology.
31:175.
2013
|
|
| 2013
|
Effects of flattening filter-free and volumetric-modulated arc therapy delivery on treatment efficiency.
Journal of Applied Clinical Medical Physics.
14:155-166.
2013
|
|
| 2013
|
Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy.
Journal of Applied Clinical Medical Physics.
14:4126.
2013
|
|
| 2013
|
Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy.
Journal of Applied Clinical Medical Physics.
14:64-71.
2013
|
|
| 2013
|
Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients..
ISRN Oncology.
2013:941269.
2013
|
|
| 2012
|
Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry..
Prostate Cancer.
2012:546794.
2012
|
|
| 2011
|
Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.
Radiotherapy and Oncology.
101:183-189.
2011
|
|
| 2011
|
Cetuximab augments cytotoxicity with poly (ADP-Ribose) polymerase inhibition in head and neck cancer.
PLoS ONE.
6.
2011
|
|
| 2011
|
Efficacy and rectal toxicity of hypofractionated radiation therapy with daily image guidance..
Journal of Clinical Oncology.
29:85.
2011
|
|
| 2011
|
Dosimetric analysis of imaging changes following pulmonary stereotactic body radiation therapy.
Australasian Radiology.
55:90-96.
2011
|
|
| 2011
|
Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide.
Australasian Radiology.
55:77-81.
2011
|
|
| 2010
|
Margin on Gross Tumor Volume and Risk of Local Recurrence in Head-and-Neck Cancer.
International Journal of Radiation Oncology - Biology - Physics.
76:164-168.
2010
|
|
| 2009
|
Cancer of the tonsil presenting as central nervous system metastasis: A case report.
Head & neck surgery.
31:127-130.
2009
|
|
| 2006
|
Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: A phase I study.
Anti-Cancer Drugs.
17:95-102.
2006
|
|
